目的:应用Time-SLIP技术结合3D TRANCE和3D Balanced FFE进行非增强肝门静脉成像,评估两种方法在肝门静脉成像中的各自优势。方法:22名健康志愿者进行Time-SLIP 3D TRANCE和Time-SLIP 3D Balanced FFE肝门静脉血管成像,测量血管信噪比(S...目的:应用Time-SLIP技术结合3D TRANCE和3D Balanced FFE进行非增强肝门静脉成像,评估两种方法在肝门静脉成像中的各自优势。方法:22名健康志愿者进行Time-SLIP 3D TRANCE和Time-SLIP 3D Balanced FFE肝门静脉血管成像,测量血管信噪比(SNR)、对比噪声比(CNR),并对图像质量进行主观评分。结果:Time SLIP 3D TRANCE和Time SLIP 3D Balanced FFE图像测量的脾静脉、肠系膜.上静脉、门静脉主于、肝内两个主要分支的信噪比(SNR)和对比噪声比(CNR)统计学上均有显著性差异(P<0.01)。Time-SLIP 3D TRANCE图像中肝内门静脉右主干显示4级分支计数优于Time-SLIP 3D Balanced FFE(P<0.05)。两种成像方法图像质量评分有统计学显薯差异(P<0.05)。结论:时间-空间标记反转脉冲3D TRANCE和3D Balanced FFE两种成像方法均可用于肝门静脉成像,3D TRANCE获得的图像质量优于3D Balanced FFE.展开更多
Objective: To investigate the clinical effect of Xinqingning (XQN), a preparation of rhubarb, combined with low dose continuous gastrointestinal dialysis in treating uremia.Methods: Patients of uremia were divided int...Objective: To investigate the clinical effect of Xinqingning (XQN), a preparation of rhubarb, combined with low dose continuous gastrointestinal dialysis in treating uremia.Methods: Patients of uremia were divided into three groups at random, 18 patients in group A were treated with 1000 ml gastrointestinal dialysate (non-absorbed mannitol solution) orally 2–3 times a day, 20 patients in group B treated with the same therapy as that in group A, also combined with XQN 5–10 tablets 3 times per day and 19 patients in group C treated with orally taken coated aldehyde oxystarch 5–10 g, 3 times a day. The therapeutic course for the three groups was 11 months. The changes in clinical manifestation, renal function, nutritional condition, and electrolytes before and after treatment were observed.Results: After treatment, significant improvement was revealed in aspects of uremic symptoms, quality of life, nutritional condition, serum creatinine, urea nitrogen, serum phosphate, uric acid, CO2 combining power, creatine clearance, body weight and arm muscular circumference in group A and B, as compared with those in group C. In comparison of group A with B, group B showed a lower serum triglyceride and a slower progression of chronic renal failure (CRF). All the criteria were not improved in group C and with serum creatinine being raised significantly.Conclusion: XQN combined with low dose continuous gastrointestinal dialysis therapy was definitely effective in treating uremia. It provides a new therapeutic means of non-replacement therapy for CRF with uremia.展开更多
文摘目的:应用Time-SLIP技术结合3D TRANCE和3D Balanced FFE进行非增强肝门静脉成像,评估两种方法在肝门静脉成像中的各自优势。方法:22名健康志愿者进行Time-SLIP 3D TRANCE和Time-SLIP 3D Balanced FFE肝门静脉血管成像,测量血管信噪比(SNR)、对比噪声比(CNR),并对图像质量进行主观评分。结果:Time SLIP 3D TRANCE和Time SLIP 3D Balanced FFE图像测量的脾静脉、肠系膜.上静脉、门静脉主于、肝内两个主要分支的信噪比(SNR)和对比噪声比(CNR)统计学上均有显著性差异(P<0.01)。Time-SLIP 3D TRANCE图像中肝内门静脉右主干显示4级分支计数优于Time-SLIP 3D Balanced FFE(P<0.05)。两种成像方法图像质量评分有统计学显薯差异(P<0.05)。结论:时间-空间标记反转脉冲3D TRANCE和3D Balanced FFE两种成像方法均可用于肝门静脉成像,3D TRANCE获得的图像质量优于3D Balanced FFE.
文摘Objective: To investigate the clinical effect of Xinqingning (XQN), a preparation of rhubarb, combined with low dose continuous gastrointestinal dialysis in treating uremia.Methods: Patients of uremia were divided into three groups at random, 18 patients in group A were treated with 1000 ml gastrointestinal dialysate (non-absorbed mannitol solution) orally 2–3 times a day, 20 patients in group B treated with the same therapy as that in group A, also combined with XQN 5–10 tablets 3 times per day and 19 patients in group C treated with orally taken coated aldehyde oxystarch 5–10 g, 3 times a day. The therapeutic course for the three groups was 11 months. The changes in clinical manifestation, renal function, nutritional condition, and electrolytes before and after treatment were observed.Results: After treatment, significant improvement was revealed in aspects of uremic symptoms, quality of life, nutritional condition, serum creatinine, urea nitrogen, serum phosphate, uric acid, CO2 combining power, creatine clearance, body weight and arm muscular circumference in group A and B, as compared with those in group C. In comparison of group A with B, group B showed a lower serum triglyceride and a slower progression of chronic renal failure (CRF). All the criteria were not improved in group C and with serum creatinine being raised significantly.Conclusion: XQN combined with low dose continuous gastrointestinal dialysis therapy was definitely effective in treating uremia. It provides a new therapeutic means of non-replacement therapy for CRF with uremia.
